CTV Morning Live Regina | CTV Morning Live

CTVNews.ca Top Stories

Merck Canada to manufacture COVID-19 antiviral drug in Canada for global distribution

In a deal Ottawa hopes will help jump-start Canada's biomanufacturing industry and better secure its supply chain for future public health emergencies, Merck Canada is partnering with Thermo Fisher Scientific to manufacture its COVID-19 antiviral drug, molnupiravir, in Canada for global distribution.

This undated image provided by Merck & Co. shows their new antiviral medication. (Merck & Co. via AP)

With the new Omicron variant, should you wait to get your booster shot?

While questions remain about the effectiveness of current vaccines in protecting against the new Omicron COVID-19 variant, experts insist that anyone who is eligible should still get their booster shot.

Ontario not likely to wind down vaccine passport system in January if Omicron persists: health minister

Ontario's deputy premier says the vaccine passport system may not start to wind down next month as planned if the Omicron coronavirus variant proves itself a greater danger to the public than Delta.

Next pandemic could be more lethal than COVID-19, Oxford-AstraZeneca vaccine creator says

Future pandemics could be even more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.